SCHEMBL637498

SCHEMBL637498

CC(=O)NN1CCCCC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.43
ALDH1A1 P00352 3/20 0.41
CYP3A4 P08684 2/20 0.41
KDM4E B2RXH2 2/20 0.41
GAA P10253 2/20 0.41
MAPT P10636 2/20 0.41
TP53 P04637 1/20 0.41
GLA P06280 1/20 0.41
ALOX12 P18054 1/20 0.41
NFKB1 P19838 1/20 0.41
LIPE Q05469 2/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C19 P33261 1/20 0.38
GFER P55789 1/20 0.38
LMNA P02545 1/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6123494 1.00 HTT (0.45) HTTL3MBTL1ALDH1A1CYP3A4KDM4E
SCHEMBL715894 0.97
SCHEMBL19052251 0.92
SCHEMBL29107984 0.90 CA2 (0.41) HTTL3MBTL1ALDH1A1CYP3A4KDM4E
SCHEMBL8033657 0.87 HTT (0.50) HTTL3MBTL1ALDH1A1CYP3A4KDM4E
SCHEMBL9613513 0.86
Trifluoroacetic Acid SCHEMBL6218638 0.83 HTT (0.38) HTTL3MBTL1ALDH1A1CYP3A4KDM4E
SCHEMBL27412940 0.81 HTT (0.49) HTTALDH1A1CYP3A4KDM4EGAA
SCHEMBL14500231 0.80 CA12 (0.53) HTTGAALIPEMEN1KMT2A
SCHEMBL4685447 0.78 HTT (0.31) HTTL3MBTL1CA12CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 428 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210038589-A1 USES, COMPOSITIONS AND METHODS FISAHN ANDRE (SE) 2021-02-11 US claimed
EP-3765082-A1 USES, COMPOSITIONS AND METHODS Fisahn, André (SE) 2021-01-20 EP claimed
WO-2019175395-A1 USES, COMPOSITIONS AND METHODS FISAHN ANDRE (SE) 2019-09-19 WO claimed
CN-109575045-A Thienopyrimidines, preparation method, Pharmaceutical composition and its application 南京红云生物科技有限公司 2019-04-05 CN claimed
CN-107698603-A Thienopyrimidines, its preparation method, Pharmaceutical composition and its application 厦门大学 2018-02-16 CN claimed
EP-1506961-B1 Processes for resolving piperidyl acetamide stereoisomers CELGENE CORP (US) 2012-02-22 EP claimed
EP-1265866-B1 ARYL SUBSTITUTED PYRIDINES, PYRIMIDINES, PYRAZINES AND TRIAZINES AND THE USE THEREOF EURO CELTIQUE SA (LU) 2010-07-21 EP claimed
US-7459560-B2 Processes and intermediates for resolving piperidyl acetamide stereoisomers CELGENE CORPORATION (US) 2008-12-02 US claimed
US-20060142583-A1 Processes and intermediates for resolving piperidyl acetamide stereoisomers KHETANI VIKRAM 2006-06-29 US claimed
US-6962997-B1 Process and intermediates for resolving piperidyl acetamide steroisomers CELGENE CORPORATION (US) 2005-11-08 US claimed
EP-0983238-B1 PROCESSES AND INTERMEDIATES FOR RESOLVING PIPERIDYL ACETAMIDE STEREOISOMERS CELGENE CORP (US) 2004-08-18 EP claimed
EP-0690889-B1 LIGHT STABILIZER PACKAGES FOR PARTIAL PAINT APPLICATIONS SOLVAY ENGINEERED POLYMERS (US) 2002-07-31 EP claimed
US-6359139-B1 REACTING 1-THREO-PIPERIDYL ACETAMIDE WITH AN ALKANOIC ACID IN SOLVNET CELGENE CORPORATION 2002-03-19 US claimed
EP-0983238-A4 PROCESSES AND INTERMEDIATES FOR RESOLVING PIPERIDYL ACETAMIDE STEREOISOMERS CELGENE CORP (US) 2001-08-08 EP claimed
US-6051637-A MOLDED COMPOSITION THAT DOES NOT INTERFER WITH ACID CURATIVE COATINGS OF THERMOPLASTIC POLYOLEFIN, MONOMERIC AND POLYMERIC HINDERED AMINE LIGHT STABILIZER(HALS) HAVING A PKA OF NO GREATER THAN 7, AND AN ULTRAVIOLET LIGHT ABSORBER SOLVAY ENGINEERED POLYMERS (US) 2000-04-18 US claimed
EP-0983238-A1 PROCESSES AND INTERMEDIATES FOR RESOLVING PIPERIDYL ACETAMIDE STEREOISOMERS CELGENE CORPORATION (US) 2000-03-08 EP claimed
US-5936091-A Processes and intermediates for resolving piperidyl acetamide stereoisomers CELGENE CORPORATION (US) 1999-08-10 US claimed
WO-1998052921-A1 PROCESSES AND INTERMEDIATES FOR RESOLVING PIPERIDYL ACETAMIDE STEREOISOMERS CELGENE CORPORATION (US) 1998-11-26 WO claimed
US-5733956-A COMPRISES A THERMOPLASTIC OLEFIN, A MONOMERIC AND A POLYMERIC HINDERED AMINE LIGHT STABILIZER AND AN ULTRAVIOLET LIGHT ABSORBING BENZOTRIAZOLE SOLVAY ENGINEERED POLYMERS (US) 1998-03-31 US claimed
EP-0188805-B1 1,3-DITHIOLE DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 1989-09-06 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210038589-A1 USES, COMPOSITIONS AND METHODS APP, CACNA1G, CACNA1B HTT 146/4885L3MBTL1 4840/4885ALDH1A1 2709/4885
US-20060142583-A1 Processes and intermediates for resolving piperidyl acetamide stereoisomers NAAA, DHPS, CTPS2 HTT 2993/4885L3MBTL1 4536/4885ALDH1A1 321/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.